Since pancreatic adaptation to massive proximal small bowel resection (PSBR) may be modulated through cholecystokinin (CCK) secretion, we tested the effect of the CCK antagonist CR-1409 on this response. Male Wistar rats (n=72) weighing 220-225 g were randomised to receive either PSBR or transection/resuture followed by saline or CR-1409 (12 mg/kg daily subcutaneously). Rats were killed one, two, and three weeks postoperatively, at which time blood was obtained for CCK assay and the pancreas was assessed for proliferative activity by three parameters: nucleic acid and protein content, bromodeoxyuridine (BrdUrd) labelling index, and proliferating cell nuclear antigen (PCNA) expression. PSBR 
Accepted for publication 1 1 September 1991 The compensatory response to extensive proximal small bowel resection (PSBR) includes growth of the remaining small intestine (duodenum and ileum) and of the gastric parietal cells, causing acid hypersecretion. ' The pancreas shares in this adaptive response. Pancreatic hyperplasia can be detected as early as one week after 90% PSBR2 and persists for at least six months.' Fifty and 75% PSBR also produce early and appreciable increases in basal pancreatic secretion of water and bicarbonate, but unlike the structural adaptation, these functional changes are transient. 4 Intestinal adaptation to PSBR is controlled by both luminal and humoral factors,' but since the pancreas lies outside the alimentary tract, only systemic factors seem likely to mediate its adaptive response. There are several candidate gastrointestinal hormones for the role of 'pancreatotropin'. Although long term administration of pentagastrin can stimulate pancreatic growth and enterectomy causes hypergastrin- 5 6 aemia, studies in rats with antrectomy or vagotomy have excluded its involvement in the response to PSBR.78 Circulating levels of insulin, pancreatic glucagon, and neurotensin are unchanged after small bowel resection, whereas enteroglucagon is increased and concentrations correlate with indices of musocal mass and cell turnover in the pancreas.`Cholecystokinin is also increased 12 peptides that produced half maximal inhibition of binding of tracer to A2 were 2-0 pmol/l for CCK-8, 2.4 pmol/l for CCK-33, and 212 nmol/l for gastrin 17 . The coefficient of variation within assays was 8.2% and between assays 12.8%. The sensitivity of the assay (defined as minimal amount of CCK-8 that could be distinguished from zero with 95% confidence) was 0.2 pmol, and the recovery of CCK-8 and CCK-33 through the SepPak and assay procedure was 79%. (Fig 1) There were two deaths from anastomotic leakage (one control and one PSBR rat). Rats undergoing massive small bowel resection weighed less than controls both at one and two weeks whether or not they received CR-1409 (8-14% less at one week, p<0001; 10-24% less at two weeks, p<0001). By three weeks, resection rats weighed 15% less than controls, but there was no difference in body weight between the resection and transection animals receiving CR-1409.
Results

MORTALITY AND BODY WEIGHT
PANCREATIC WEIGHT (Fig 2) Proximal small bowel resection had a clearcut effect on both absolute and relative pancreatic weight. Absolute pancreatic weight was 4.9-9% less than controls at one week but was 18% greater than controls at two weeks and 27% greater at three weeks. Likewise, enterectomy caused a 32% increase in relative pancreatic weight over controls at two weeks and a 50% increase at three weeks. CR-1409 completely abolished this pancreatic growth, so that differences in absolute and relative pancreatic weights between resection and transection animals were no longer significant. (Table) Small bowel resection caused a sustained increase in circulating CCK concentrations -by 83% at one week, by 102% at two weeks, and by 96% at three weeks. Administration of CR-1409 had no appreciable effect on plasma hormone concentrations.
NUCLEIC ACID AND PROTEIN CONTENTS (Fig 3) Pancreatic nucleic acid and protein contents increased after proximal small bowel resection, but the increase did not attain statistical significance until two weeks, when DNA was 34% higher, RNA 60% higher, and protein 20% higher than in controls. These changes were more obvious by three weeks, when increments were 82%, 178%, and 57%. With the exception of the DNA contents at two weeks, the CCK antagonist completely inhibited growth stimulation produced by PSBR.
BRDURD LABELLING INDEX (Fig 4) One week after PSBR, the labelling index was already higher than in controls (0-35 v 0.05%).
The increase in proliferative response became increasingly obvious at two weeks (1-43 v 0 20%) and was still present at three weeks (0-88 v 0-35%). CR-1409 abolished the effect of proximal enterectomy, so that there was no difference from control values at any time point. The antagonist had no effect in rats with small bowel transection.
PCNA LABELLING INDEX (Fig 5) Broadly similar results were obtained for the cell kinetic data derived by counting PCNA immunoreactive cells. PSBR caused an increase in the proliferation rate at one week (0-70 v 0%). The differences were more marked both at two weeks (4-13 v 0%) and at three weeks (2-10 v 0-55). Again, CR-1409 largely abolished the growth stimulation produced by bowel resection but had no consistent effect within the control groups. There was a correlation between the BrdUrd labelling index and the PCNA labelling index, with a Spearman correlation coefficient of 0-68.
ULTRASTRUCTURAL STUDIES
Samples of pancreas from rats with transection and saline injection showed no differences from normal pancreas. Acinar cells were typically pyramidal in shape with closely packed rough endoplasmic reticulum, numerous mitochondria and abundant apical zymogen granules (Fig 6) . By contrast, samples from animals with PSBR and saline showed incipient vacuole formation in the rough endoplasmic reticulum of many acinar cells, associated with marked degranulation (Fig  7) . No degranulation was noted in either transection or resection animals that had been treated with CR-1409, but incipient vacuolation of the rough endoplasmic reticulum was a feature of all CR-1409 treated tissues as well as those of the PSBR group (Fig 8) . 
